3
Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the market
One document
more
Stories about Pharmakologie
LTS Lohmann Therapie-Systeme AG
LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
moreSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues
moreGrünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
moreRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
moreGerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
more
Strides Pharma International AG
Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
moreInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies
more- 2
SHL Medical announces plans to establish SHL Advantec
more Event Announcement: VIROFIGHT Hybrid Symposium
One documentmoreRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
more- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
One documentmore
- 2
Record financing rounds at the Munich biotech hub
One documentmore Press release: STADA continues strong growth journey in the first half of 2024
One documentmore- 2
Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients
more - 10
Gerresheimer: New pictures available
more canSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmore- 3
canSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmore
- 2
Gerresheimer partners with RxCap to offer connected adherence solutions
more Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
morePress release: STADA continues with double-digit sales and profit growth in 2023
One documentmoreResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
moreLTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
moreRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target
more
Therapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial
moreBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
moreSHL Medical partners with SteriPack Group to set up final assembly service
morePress release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner
One documentmoreLTS Lohmann Therapie-Systeme AG
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches
moreLTS Lohmann Therapie-Systeme AG
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
more
123Next